Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
zolpidem tartrate sublingual tablet
DRUG
2 trials
Sponsors
Transcept Pharmaceuticals
Conditions
Insomnia
Phase 1
Driving Performance After Middle of the Night Administration of 3.5 mg Zolpidem Tartrate Sublingual Tablet
Completed
NCT01106859
Transcept Pharmaceuticals
Insomnia
Start: 2010-06-30
End: 2010-09-30
Updated: 2012-02-14
Phase 3
A Study of Zolpidem Tartrate Sublingual Tablet in Adult Patients With Insomnia
Completed
NCT00466193
Transcept Pharmaceuticals
Insomnia
Start: 2007-05-31
End: 2007-11-30
Updated: 2012-02-14
Related Papers
Residual Effects of Low-Dose Sublingual Zolpidem on Highway Driving Performance the Morning after Middle-of-the-Night Use
SLEEP
2014-02-28
44 citations
Novel sublingual low-dose zolpidem tablet reduces latency to sleep onset following spontaneous middle-of-the-night awakening in insomnia in a randomized, double-blind, placebo-controlled, outpatient study.
2013-02-01
26 citations